Consensus Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen 10:59:55 2024-04-12 am EDT After market 11:20:00 am
880 DKK +1.23% Intraday chart for Novo Nordisk A/S 880.6 +0.06%

Evolution of the average Target Price on Novo Nordisk A/S

Price target over the last 5 years

History of analyst recommendation changes

367f4a1f991072.bdqNVKnp3mC_E212Adf8ippg4bOX70N_0Ua5uGe1LQs.PZy-EMeMrwngZ10Ud-HLwcgJqdjF2QkvlzHM6QTFVVxdvuoH8ZDuDNZbJA~c32d24ab0c1a6bc5cca8bd469ed09a43
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target MT
NOVO NORDISK : UBS sticks Neutral ZD
NOVO NORDISK : Barclays maintains a Buy rating ZD
NOVO NORDISK : Berenberg remains Neutral ZD
NOVO NORDISK : Novo’s bag is full of pearls! Alphavalue
NOVO NORDISK : Barclays reiterates its Buy rating ZD
NOVO NORDISK : UBS sticks Neutral ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating ZD
NOVO NORDISK : Novo’s got a strong arsenal to go the distance Alphavalue
NOVO NORDISK : Buy rating from Barclays ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating ZD
NOVO NORDISK : UBS reiterates its Neutral rating ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank ZD
NOVO NORDISK : UBS reiterates its Neutral rating ZD
NOVO NORDISK : Berenberg sticks Neutral ZD
NOVO NORDISK : Berenberg remains Neutral ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating ZD
NOVO NORDISK : Barclays remains its Buy rating ZD
Forget about rate cuts... Our Logo
NOVO NORDISK : Jefferies reaffirms its Sell rating ZD
NOVO NORDISK : Novo Nordisk on course to become Europe’s first trillion dollar company? Alphavalue
NOVO NORDISK : JP Morgan remains its Buy rating ZD
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
869.3 DKK
Average target price
901.8 DKK
Spread / Average Target
+3.74%
High Price Target
1,120 DKK
Spread / Highest target
+28.84%
Low Price Target
530 DKK
Spread / Lowest Target
-39.03%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Novo Nordisk A/S

BMO Capital
UBS Jo Walton
BARCLAYS Emily Field
alphavalue Abhishek Raval
BERENBERG Kerry Holford
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
JPMORGAN Richard Vosser
JEFFERIES Peter Welford
Cantor Fitzgerald
DZ BANK Elmar Kraus
TD Cowen
Stifel Nicolaus
ODDO BHF
Berenberg Bank
CREDIT SUISSE Lorenzo Biasio
GOLDMAN SACHS Keyur Parekh
Morgan Stanley
BERNSTEIN RESEARCH Wimal Kapadia
BNP Paribas Exane
JPMorgan Chase
Guggenheim
Bryan, Garnier & Co.
Deutsche Bank Securities
DEUTSCHE BANK Emmanuel Papadakis
Liberum Capital
KEPLER CHEUVREUX David Evans
HSBC Stephen McGarry
INDEPENDENT RESEARCH Tobias Gottschalt
BANK OF AMERICA (BOFA) Sachin Jain
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. Consensus Novo Nordisk A/S